2 days agoStudy: Coronavirus patients who took this drug have twice as likely to die
Periskopi(6 years ago)
(6 years ago)Patients who received a common urth drug during hospital hospitalization for Avid-19 were twice as likely to survive infection, according to a new study. It is still unclear whether the health of patients has been improved by the famiothics drug or just a coincidence. From 1,620 patients [...]
It is still unclear whether the health of patients has been improved by the famiothics drug or just a coincidence.
Of the 1,620 patients admitted to the hospital, 84 of them, or about 5%, received the Family.
In comparison to the rest of the patients, those who took the Family had twice as little risk of losing life or intruding”, according to a statement by academic authors at Columbia University Irving Center.
It is not yet clear why those patients who received the family had improved results,” write the authors in their statement.
The study does not confirm that the family reduces the possibility of death from the Coronavirus, and it can be a coincidence.
Now a clinical test is under way to see if the Famiodina saves the lives of the coronary patients.
We hope that the results from this trial will determine that the famiodina is effective for the treatment of Covid-19”, researchers say.
